Bio-Rad Laboratories, Inc. (BIO-B) — 8-K Filings

8-K Filings (18)

• Bio-Rad Laboratories Files 8-K — Sep 30, 2025 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on September 30, 2025, reporting events as of September 29, 2025. The filing primarily concerns Regulation FD Disclosure
• Bio-Rad Laboratories Files 8-K — Aug 26, 2025 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on August 26, 2025, to report information under Regulation FD and to file financial statements and exhibits. The filing
• Bio-Rad Laboratories Announces Executive and Director Changes — Jul 28, 2025 Risk: medium
  Bio-Rad Laboratories, Inc. announced on July 28, 2025, several key executive changes. The company elected new directors, including Dr. Michael J. Gelb and Ms. S
• Bio-Rad Laboratories, Inc. Files Routine 8-K — Jun 30, 2025 Risk: low
  On June 30, 2025, Bio-Rad Laboratories, Inc. filed an 8-K report. The filing indicates no specific material events or new information beyond routine disclosures
• Bio-Rad Laboratories Reports Shareholder Vote Matters — Apr 25, 2025 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on April 25, 2025, reporting on matters submitted to a vote of security holders as of April 22, 2025. The filing details
• Bio-Rad Laboratories Files 8-K for Regulation FD Disclosure — Feb 21, 2025 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on February 21, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or ma
• Bio-Rad Laboratories Files 8-K on Financials and Operations — Feb 13, 2025 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on February 13, 2025, reporting on results of operations and financial condition as of February 7, 2025. The filing also
• Bio-Rad Laboratories Files 8-K on Financials — Oct 30, 2024 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on October 30, 2024, reporting on its results of operations and financial condition. The filing includes financial state
• Bio-Rad Laboratories Files 8-K with Bylaw & Exhibit Updates — Sep 9, 2024 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on September 9, 2024, reporting changes to its articles of incorporation or bylaws and filing financial statements and e
• Bio-Rad Appoints New CFO, Sarah E. Young — Aug 20, 2024 Risk: medium
  Bio-Rad Laboratories, Inc. announced on August 15, 2024, the appointment of Sarah E. Young as its new Chief Financial Officer, effective August 19, 2024. Young
• Bio-Rad Labs Reports Q2 Results — Aug 1, 2024 Risk: low
  Bio-Rad Laboratories, Inc. announced its financial results for the second quarter ended July 29, 2024. The company reported net sales of $678.5 million and dilu
• Bio-Rad Laboratories Files 8-K on Financials — May 7, 2024 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on May 7, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
• Bio-Rad Appoints New CFO, Sarah Young — Apr 26, 2024 Risk: medium
  Bio-Rad Laboratories, Inc. announced on April 22, 2024, the appointment of Sarah E. Young as its new Chief Financial Officer, effective May 6, 2024. Young will
• Bio-Rad Appoints New General Counsel — Apr 10, 2024 Risk: low
  Bio-Rad Laboratories, Inc. announced on April 10, 2024, the appointment of Ilan D. Danieli as its new General Counsel and Corporate Secretary, effective April 1
• Bio-Rad Appoints Ilan Daskal as New CFO — Mar 20, 2024 Risk: medium
  Bio-Rad Laboratories, Inc. announced on March 20, 2024, the appointment of Ilan D. Daskal as its new Chief Financial Officer, effective March 25, 2024. Daskal w
• Bio-Rad Laboratories Files Routine 8-K Disclosure — Feb 21, 2024 Risk: low
  Bio-Rad Laboratories, Inc. filed an 8-K on February 21, 2024, under Regulation FD Disclosure. The filing indicates an event reported on February 21, 2024, and p
• Bio-Rad Labs Files 8-K on Financial Results and Operations — Feb 15, 2024 Risk: low
  BIO-RAD LABORATORIES, INC. filed an 8-K on February 15, 2024, reporting on its Results of Operations and Financial Condition, along with Financial Statements an
• Bio-Rad Reports Multiple Material Events in 8-K Filing — Feb 14, 2024 Risk: medium
  BIO-RAD LABORATORIES, INC. filed an 8-K on February 14, 2024, reporting events that occurred on February 9, 2024. The filing indicates the company entered into

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX